Racial Differences in Secondary Hyperparathyroidism

نویسنده

  • Akihiko Kato
چکیده

Copyright © 2013, Nephrology and Urology Research Center; Licensee Kowsar Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Dear Editor, I have recently read an interesting paper by Dr. Seck who had examined the prevalence of CKD-MBD in black African (Senegalese) patients on regular hemodialysis (HD) in a cross-sectional fashion (Nephrol-Urol Mon. 2012; 4(4): 613-616) (1). They showed that 57 out of the 79 patients complicated with CKD-MBD (72%) had a high turnover bone disease with a mean level of 984 pg/mL of intact parathyroid hormone (iPTH). Because mean calcium and phosphorous levels were not elevated (8.6 and 4.85 mg/ dL), this marked increment of iPTH may be related to racial differences in the regulation of vitamin D-PTH axis. Autopsy studies have demonstrated that parathyroid mass is increased in blacks compared with whites (2). There is a 4.4-fold higher risk for severe secondary hyperparathyroidism (iPTH > 500 pg/mL) in black patients than in white patients at dialysis initiation (3). African-American HD patients have iPTH levels that are higher than expected in relation to bone histology (4). Blacks with advanced CKD not yet on dialysis also have lower 25(OH) D and higher iPTH concentrations with declining kidney function compared with whites, independent of FGF-23 concentrations (5). So, there may be a unique mechanism by which blacks develop secondary hyperparathyroidism, such as skeletal resistance to PTH, or more activation of calcium-sensing receptor in the parathyroid gland. Although current guidelines on the management of CKD-MBD recommend screening and treating abnormalities in mineral metabolism, none of them take into account for racial differences. Thus, further evaluation will be needed to realize whether current guidelines are truly adequate for all races/ethnicities.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Nutritional Secondary Hyperparathyroidism in Cats under Six-Month-Old of Ahvaz

Objective- To determine the prevalence of nutritional secondary hyperparathyroidism (NSH) in companion and stray cats of Ahvaz.   Design- Clinical study. Animals- 80 cats (companion=40 and stray=40) Procedures- This survey was accomplished during a two-year period and based on clinical, radiographic and laboratory findings between 2005 and 2007. The studied cats were divided into two gener...

متن کامل

Racial differences in clinical use of cinacalcet in a large population of hemodialysis patients.

BACKGROUND/AIMS African-Americans with end-stage renal disease receiving dialysis have more severe secondary hyperparathyroidism than Whites. We aimed to assess racial differences in clinical use of cinacalcet. METHODS This retrospective cohort study used data from DaVita, Inc., for 45,589 prevalent hemodialysis patients, August 2004, linked to Centers for Medicare & Medicaid Services data, w...

متن کامل

Myelofibrosis due to Secondary Hyperparathyroidism in a Case of Celiac Disease

Myelofibrosis is reported in patents with primary hyperparathyroidism. It is also was reported in patents with sec- ondary hyperparathyroidism due to end-stage renal disease or Vitamin D dependent rickets .We present a case of celiac disease and osteomalacia which leads to secondary hyperparathyroidism and myelofibrosis.

متن کامل

Intensification of Anemia by Secondary Hyperparathyroidism in Hemodialysis Patients

The excessive amounts of parathyroid hormone in secondary hyperparathyroidism (SHPTH) is suggested to interfere with normal erythropoiesis.  In SHPTH, during chronic renal failure, due to the impairment of erythropoietin synthesis, this effect is more pronounced.  In the present study the role of secondary hyperparathyroidism in the severity of anemia was evaluated in hemodialysis patients (n=3...

متن کامل

The role of secondary hyperparathyroidism in anemia of end stage renal disease

Introduction: secondary hyperparathyroidism is listed among the possible reasons for intensifying the anemia and resistance to erythropoietin therapy in hemodialysis patients. Although its exact mechanism is not entirely clarified, but shift of bone marrow cells to adipocytes, bone marrow fibrosis and decreased calciteriol can be the causes. However, the role of secondary hyperparathyroidism in...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 5  شماره 

صفحات  -

تاریخ انتشار 2013